Soluble TREM2 is elevated in Parkinson’s disease subgroups with increased CSF tau
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Soluble TREM2 is elevated in Parkinson’s disease subgroups with increased CSF tau
Authors
Keywords
-
Journal
BRAIN
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-01-18
DOI
10.1093/brain/awaa021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology
- (2019) Marc Suárez-Calvet et al. Molecular Neurodegeneration
- Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model
- (2019) Li Zhong et al. Nature Communications
- Progressive parkinsonism in older adults is related to the burden of mixed brain pathologies
- (2019) Aron S. Buchman et al. NEUROLOGY
- Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis
- (2019) Silvia Paciotti et al. CLINICA CHIMICA ACTA
- Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Aβ42 and T-Tau assays for Alzheimer’s disease diagnosis
- (2019) Jean-Louis Bayart et al. JOURNAL OF NEUROLOGY
- Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer’s disease
- (2019) Michael Ewers et al. Science Translational Medicine
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated
- (2018) John L Robinson et al. BRAIN
- TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson's disease
- (2018) Manru Ren et al. EXPERIMENTAL NEUROLOGY
- The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer’s disease
- (2018) Paul J. Cheng-Hathaway et al. Molecular Neurodegeneration
- Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease
- (2018) Brenna Cholerton et al. PARKINSONISM & RELATED DISORDERS
- APOE ε4 is associated with severity of Lewy body pathology independent of Alzheimer pathology
- (2018) Dennis W. Dickson et al. NEUROLOGY
- Finding useful biomarkers for Parkinson’s disease
- (2018) Alice S. Chen-Plotkin et al. Science Translational Medicine
- Serum Soluble Triggering Receptor Expressed on Myeloid Cells 2 as a Biomarker for Incident Dementia: The Hisayama Study
- (2018) Tomoyuki Ohara et al. ANNALS OF NEUROLOGY
- CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
- (2018) Kristi Henjum et al. Journal of Neuroinflammation
- Comparative sensitivity of the MoCA and Mattis Dementia Rating Scale‐2 in Parkinson's disease
- (2018) Taylor R. Hendershott et al. MOVEMENT DISORDERS
- Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE
- (2018) Samira Parhizkar et al. NATURE NEUROSCIENCE
- The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort
- (2018) Kenneth Marek et al. Annals of Clinical and Translational Neurology
- Domain-specific accuracy of the Montreal Cognitive Assessment subsections in Parkinson's disease
- (2017) Taylor R. Hendershott et al. PARKINSONISM & RELATED DISORDERS
- Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
- (2017) Piotr Lewczuk et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Pooled Analyses on Cognitive Effects of Memantine in Patients with Moderate to Severe Alzheimer's Disease
- (2017) Murat Emre et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
- (2016) Laura Piccio et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease
- (2016) Juan Domingo Gispert et al. Alzheimers & Dementia
- sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
- (2016) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- Cerebrospinal Fluid Alzheimer’s Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort
- (2016) Inger van Steenoven et al. JOURNAL OF ALZHEIMERS DISEASE
- Neuroprotective Effect of TREM-2 in Aging and Alzheimer’s Disease Model
- (2016) Animesh Alexander Raha et al. JOURNAL OF ALZHEIMERS DISEASE
- TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
- (2016) Yaming Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
- (2016) Amanda Heslegrave et al. Molecular Neurodegeneration
- TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia
- (2016) Felix L. Yeh et al. NEURON
- Early changes in CSF sTREM2 in dominantly inherited Alzheimers disease occur after amyloid deposition and neuronal injury
- (2016) M. Suarez-Calvet et al. Science Translational Medicine
- Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
- (2016) Kristi Henjum et al. Alzheimers Research & Therapy
- TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
- (2014) G. Kleinberger et al. Science Translational Medicine
- Sequential Proteolytic Processing of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Protein by Ectodomain Shedding and γ-Secretase-dependent Intramembranous Cleavage
- (2013) Patrick Wunderlich et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease
- (2013) Sruti Rayaprolu et al. Molecular Neurodegeneration
- TREM2 is associated with the risk of Alzheimer's disease in Spanish population
- (2013) Bruno A. Benitez et al. NEUROBIOLOGY OF AGING
- Variant of TREM2 Associated with the Risk of Alzheimer's Disease
- (2012) Thorlakur Jonsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- TREM2 Variants in Alzheimer's Disease
- (2012) Rita Guerreiro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Total-tau in cerebrospinal fluid of patients with multiple sclerosis decreases in secondary progressive stage of disease and reflects degree of brain atrophy
- (2012) Jacek Jaworski et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- APOE ϵ4 Increases Risk for Dementia in Pure Synucleinopathies
- (2012) Debby Tsuang et al. JAMA Neurology
- Abnormal tau phosphorylation in primary progressive multiple sclerosis
- (2010) Jane Marian Anderson et al. ACTA NEUROPATHOLOGICA
- A recommended scale for cognitive screening in clinical trials of Parkinson's disease
- (2010) Kelvin L. Chou et al. MOVEMENT DISORDERS
- Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and β-catenin
- (2009) Karel Otero et al. NATURE IMMUNOLOGY
- Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis
- (2008) J. M. Anderson et al. BRAIN
- Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation
- (2008) Laura Piccio et al. BRAIN
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
- (2008) Mariese A. Hely et al. MOVEMENT DISORDERS
- Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study
- (2008) D. Aarsland et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started